Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03054389 · ClinicalTrials.gov registry record
Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator Interviews
A clinical trial, sponsored by Baxalta now part of Shire.
- Completed
- Registry status
- 27
- Enrollment target
NCT03054389 is a clinical trial that has completed, run by Baxalta now part of Shire. The registered enrollment target is 27 participants.
The verdict
NCT03054389 has completed, sponsored by Baxalta now part of Shire.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The purpose of this study is to seek to understand the patient's perspective around deciding to participate in a clinical trial for a Hemophilia therapy
Interventions
- OTHER Qualitative Interview - Participants/ Patients
- OTHER Qualitative Interview - Investigators and Study Coordinators
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2017-03-31 |
| Est. Completion | 2017-06-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03054389
The ClinicalTrials.gov registry entry for NCT03054389 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baxalta now part of Shire, which has 74 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Qualitative Interview - Participants/ Patients is the first listed.
NCT03054389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03054389 about?
NCT03054389 is a clinical study titled "Non-Interventional Study to Capture the Patient Experience on Gene Therapy for Hemophilia Within the AskBio009-101 Study Through Patient and Investigator Interviews". The purpose of this study is to seek to understand the patient's perspective around deciding to participate in a clinical trial for a Hemophilia therapy
What is the current status of trial NCT03054389?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2017-03-31. Estimated completion is 2017-06-06.
What interventions are being tested in trial NCT03054389?
The interventions under investigation include: Qualitative Interview - Participants/ Patients (OTHER), Qualitative Interview - Investigators and Study Coordinators (OTHER).
Who is sponsoring clinical trial NCT03054389?
This trial is sponsored by Baxalta now part of Shire, which has 74 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.